Information détaillée concernant le cours

[ Retour ]
Titre

Biotechnology development (+CILS)

Dates

24.04.2017, 8:30-12:00; 25.04.2017: 08:30-11:15; 27.04.2017: 13:15-15:00; 02.05.2017: 08:30-12:00 et 13:30-15:00; 04.05.2017: 13:30-15:15; 08.05.2017: 11:00-12:00 et 13:30-15:15

Organisateur(s)/trice(s)

Prof Y. Kalia, professeur associé, Section des sciences pharmaceutiques, Université de Genève

Intervenant-e-s

Dr Marie KOSCO-VILLEBOIS (CSO, NovImmune ) Dr Amanda PROUDFOOT Dr Zoe JOHNSON Dr Nicolas FISCHER Giovanni MAGISTRELLI Dr Keith WILSON Alexandre CARRON Dr Vanessa BUATOIS Dr Robert NELSON Dr Susana SALGADO-PIRES Rebeca ZORILLA Dr Krzysztof MASTERNAK Dr Walter FERLIN

Description

Course Outline:

• Overview of the steps for drug development (2h, MKV)

• Choosing and validating a protein as a target for pharmaceutical intervention (2h, ZJ)

• Discovering a therapeutic macromolecule with an emphasis on antibodies (monoclonal, bispecific, fragments) (2h, NF)

• Generating a robust toolbox and screening approaches (1h, GM)

• Steps in manufacturing antibodies (1h, KW)

• Manufacturing a drug for market: process validation (1h, AC)

• In vitro and in vivo pharmacology studies (2h, VB)

• Testing samples from clinical trials and the notion of GCP (2h, RN)

• Nonclinical safety: toxicology and other safety considerations before entering humans (2h, SS-P)

• Pulling it all together: Project management (1h, RZ)

• Awaking the immune system to fight cancer by targeting CD47 (1h, KM)

• Targeting chemokines: successes and failures (1h, AP)

• Targeting rare diseases: The orphan story (2h, WF)

Lieu

UNIGE, CMU, room A04.3011

Information
Places

12

Délai d'inscription 12.04.2017
short-url short URL

short-url URL onepage